Literature DB >> 17189265

Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans.

Claudia Pönighaus1, Michael Ambrosius, Javier Carrera Casanova, Christian Prante, Joachim Kuhn, Jeffrey D Esko, Knut Kleesiek, Christian Götting.   

Abstract

Human xylosyltransferase I (XT-I) initiates the biosynthesis of the glycosaminoglycan (GAG) linkage tetrasaccharide in proteoglycans. Xylosyltransferase II (XT-II) is a protein homologous to XT-I but with hitherto unknown activity or physiological function. Here, we report the enzymatic activity of XT-II and provide evidence that XT-II initiates the biosynthesis of both heparan sulfate and chondroitin sulfate GAGs. Transfection of the xylosyltransferase-deficient Chinese hamster ovary mutant pgsA-745 with XT-I or XT-II coding cDNA completely restored GAG biosynthesis. GAG disaccharide analysis revealed that XT-I- and XT-II-transfected pgsA-745 cells produced similar amounts of chondroitin sulfate and heparan sulfate. Furthermore, a high xylosyltransferase activity was measured after transfection with cDNAs encoding either isozyme. Analysis of the enzyme activity revealed that XT-II catalyzes the transfer of xylose to similar peptide acceptors as XT-I but with different efficiency. The optimal XT-II acceptor was observed using a bikunin-related peptide (K(m) 5.2 microM). Analysis of XT-I and XT-II mRNA expression in murine tissues showed a differential expression pattern for both enzymes. In particular, XT-II is highly expressed in liver tissue, where XT-I transcripts were not detected. This is the first report on the enzyme activity of XT-II and its involvement in chondroitin sulfate and heparan sulfate biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189265     DOI: 10.1074/jbc.M611665200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3.

Authors:  Birgit S Budde; Shuji Mizumoto; Ryo Kogawa; Christian Becker; Janine Altmüller; Holger Thiele; Franz Rüschendorf; Mohammad R Toliat; Gerrit Kaleschke; Johannes M Hämmerle; Wolfgang Höhne; Kazuyuki Sugahara; Peter Nürnberg; Ingo Kennerknecht
Journal:  Hum Genet       Date:  2015-04-19       Impact factor: 4.132

2.  Involvement of a cysteine protease in the secretion process of human xylosyltransferase I.

Authors:  Claudia Pönighaus; Joachim Kuhn; Knut Kleesiek; Christian Götting
Journal:  Glycoconj J       Date:  2010-03-03       Impact factor: 2.916

3.  XYLT1 mutations in Desbuquois dysplasia type 2.

Authors:  Catherine Bui; Céline Huber; Beyhan Tuysuz; Yasemin Alanay; Christine Bole-Feysot; Jules G Leroy; Geert Mortier; Patrick Nitschke; Arnold Munnich; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

Review 4.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

5.  First identification and functional analysis of the human xylosyltransferase II promoter.

Authors:  Benjamin Müller; Christian Prante; Cornelius Knabbe; Knut Kleesiek; Christian Götting
Journal:  Glycoconj J       Date:  2012-08-11       Impact factor: 2.916

6.  High xylosyltransferase activity in children and during mineralization of osteoblast-like SAOS-2 cells.

Authors:  Christian Prante; Joachim Kuhn; Knut Kleesiek; Christian Götting
Journal:  Glycoconj J       Date:  2008-09-02       Impact factor: 2.916

7.  Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum.

Authors:  Eduard Condac; George L Dale; Diane Bender-Neal; Beatrix Ferencz; Rheal Towner; Myron E Hinsdale
Journal:  Glycobiology       Date:  2009-04-23       Impact factor: 4.313

Review 8.  Characterization of C. elegans Chondroitin Proteoglycans and Their Large Functional and Structural Heterogeneity; Evolutionary Aspects on Structural Differences Between Humans and the Nematode.

Authors:  Fredrik Noborn; Göran Larson
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis.

Authors:  Eduard Condac; Robert Silasi-Mansat; Stanley Kosanke; Trenton Schoeb; Rheal Towner; Florea Lupu; Richard D Cummings; Myron E Hinsdale
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

10.  Forward genetics defines Xylt1 as a key, conserved regulator of early chondrocyte maturation and skeletal length.

Authors:  Emily K Mis; Karel F Liem; Yong Kong; Nancy B Schwartz; Miriam Domowicz; Scott D Weatherbee
Journal:  Dev Biol       Date:  2013-10-23       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.